Gene · 9656
Papers2,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Whole-Genome CRISPR Screen Identifies AHR Loss as a Mechanism of Resistance to a PARP7 Inhibitor. | Mol Cancer Ther | 2022 | 35439318 | PubTator, text mining | PubMed |
| The paradigm of drug resistance in cancer: an epigenetic perspective. | Biosci Rep | 2022 | 35438143 | PubTator, text mining | PubMed |
| Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection. | Front Immunol | 2022 | 35422799 | PubTator, text mining | PubMed |
| IKZF1 selectively enhances homologous recombination repair by interacting with CtIP and USP7 in multiple myeloma. | Int J Biol Sci | 2022 | 35414773 | PubTator, text mining | PubMed |
| Whole-exome sequencing in patients with maturation arrest: a potential additional diagnostic tool for prevention of recurrent negative testicular sperm extraction outcomes. | Hum Reprod | 2022 | 35413094 | PubTator, text mining | PubMed |
| In Mitosis You Are Not: The NIMA Family of Kinases in Aspergillus, Yeast, and Mammals. | Int J Mol Sci | 2022 | 35409400 | PubTator, text mining | PubMed |
Characterization of Aberrations in DNA Damage Repair Pathways in Gastrointestinal Stromal Tumors: The Clinicopathologic Relevance of γH2AX and 53BP1 in Correlation with Heterozygous Deletions of CHEK2, BRCA2, and RB1. | Cancers (Basel) | 2022 | 35406559 | PubTator, text mining | PubMed |
| Parvovirus nonstructural protein 2 interacts with chromatin-regulating cellular proteins. | PLoS Pathog | 2022 | 35395063 | PubTator, text mining | PubMed |
| PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy. | Front Oncol | 2022 | 35392233 | PubTator, text mining | PubMed |
| Expression of DNA-damage response and repair genes after exposure to DNA-damaging agents in isogenic head and neck cells with altered radiosensitivity. | Radiol Oncol | 2022 | 35390246 | PubTator, text mining | PubMed |
| Analysis of the genomic landscapes of Barbadian and Nigerian women with triple negative breast cancer. | Cancer Causes Control | 2022 | 35384527 | PubTator, text mining | PubMed |
| Physical and functional interactome atlas of human receptor tyrosine kinases. | EMBO Rep | 2022 | 35384245 | PubTator, text mining | PubMed |
| Monocyte subpopulation profiling indicates CDK6-derived cell differentiation and identifies subpopulation-specific miRNA expression sets in acute and stable coronary artery disease. | Sci Rep | 2022 | 35379829 | PubTator, text mining | PubMed |
| Functional defects of cancer-associated MDC1 mutations in DNA damage repair. | DNA Repair (Amst) | 2022 | 35378404 | PubTator, text mining | PubMed |
| Cytotoxicity, crosslinking and biological activity of three mitomycins. | Bioorg Chem | 2022 | 35349830 | PubTator, text mining | PubMed |
| Insights in Post-Translational Modifications: Ubiquitin and SUMO. | Int J Mol Sci | 2022 | 35328702 | PubTator, text mining | PubMed |
| Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer. | Cancers (Basel) | 2022 | 35326540 | PubTator, text mining | PubMed |
| PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth. | BMC Cancer | 2022 | 35321693 | PubTator, text mining | PubMed |
| Quantification of histone H2AX phosphorylation in white blood cells induced by ex vivo gamma irradiation of whole blood by both flow cytometry and foci counting as a dose estimation in rapid triage. | PLoS One | 2022 | 35320288 | PubTator, text mining | PubMed |
| Expression of BRCA1, BRCA2, RAD51, and other DSB repair factors is regulated by CRL4WDR70. | DNA Repair (Amst) | 2022 | 35316728 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9656/papers?page=23